Drug profile · INN
gadobenate dimeglumine
MULTIHANCE
gadobenate dimeglumine (MULTIHANCE) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — gadobenate dimeglumine
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gadobenate dimeglumine (MULTIHANCE) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is gadobenate dimeglumine?
gadobenate dimeglumine (MULTIHANCE) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for gadobenate dimeglumine?
MULTIHANCE is a marketed brand name for gadobenate dimeglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadobenate dimeglumine?
gadobenate dimeglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.